Yeon Tae Jeong

Title: Yeon Tae Jeong: Innovator in Glycoprotein Production

Introduction

Yeon Tae Jeong is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant glycoproteins. His innovative methods have the potential to enhance the efficacy of various therapeutic proteins.

Latest Patents

Yeon Tae Jeong holds a patent for a method for preparing recombinant glycoproteins with high sialic acid content. This patent describes a process involving the UDP-GlcNAc 2-epimerase/ManNAc kinase (GNE/MNK) enzyme. The method includes point mutations that maintain epimerase activity while increasing the intracellular content of CMP-sialic acid in host cells. This advancement is particularly beneficial for producing glycoproteins such as erythropoietin and thrombopoietin with enhanced sialic acid content.

Career Highlights

Yeon Tae Jeong is affiliated with the Korea Advanced Institute of Science and Technology, where he conducts his research. His work has garnered attention for its potential applications in the pharmaceutical industry, particularly in the development of more effective therapeutic agents.

Collaborations

He collaborates with notable colleagues, including Jung Hoe Kim and Young Dok Son, who contribute to his research endeavors. Their combined expertise enhances the innovative approaches taken in their projects.

Conclusion

Yeon Tae Jeong's contributions to the field of glycoprotein production exemplify the impact of innovative research in biotechnology. His patented methods pave the way for advancements in therapeutic protein development, showcasing the importance of scientific innovation in healthcare.